Biogen reported $30.95B in Market Capitalization this March of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US $ 286.33B 46.96B
Acadia Pharmaceuticals ACAD:US $ 3.91B 0.15B
Acorda Therapeutics ACOR:US $ 0.02B 0.01B
Amgen AMGN:US $ 129.08B 2.36B
Bayer BAYN:GR 61.51B 15.23B
Biogen BIIB:US $ 30.95B 4.29B
Biomarin Pharmaceutical BMRN:US $ 14.26B 1.96B
Bluebird Bio BLUE:US $ 0.35B 0.35B
Bristol Myers Squibb BMY:US $ 155.49B 17.09B
Esperion Therapeutics ESPR:US $ 0.29B 0.02B
Gilead Sciences GILD:US $ 74.66B 16.42B
Merk MRK:US $ 207.45B 13.86B
Novartis NOVN:VX 197.8B 2.36B
Sangamo Biosciences SGMO:US $ 0.85B 0.24B
Sanofi SAN:FP 111.92B 6.96B
Sanofi SNY:US 129.35B 2.11B
Teva Pharmaceutical TEVA:IT 32.84B 3.11B
Ultragenyx Pharmaceutical RARE:US $ 5.04B 0.69B
United Therapeutics UTHR:US $ 8.12B 1.61B